BIJUVA
BIJUVA
Approved
DIN Number
02505223
Drug Class
Human
Market Date
Jan 31, 2024
Company
HC
knight therapeutics inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505223
AIG Number0254135003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03FA04 PROGESTERONE AND ESTROGEN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification68:32.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
ESTRADIOL (ESTRADIOL HEMIHYDRATE)Active
Strength: 1 MG
Monograph: ESTRADIOL (ESTRADIOL HEMIHYDRATE)
PROGESTERONEActive
Strength: 100 MG
Monograph: PROGESTERONE